Cluster Headache in Canada

In Canada, psychedelics that could help cluster headache patients (including psilocybin, LSD, and DMT) are classified as controlled substances under the federal Controlled Drugs and Substances Act (CDSA). Most psychedelics fall under Schedule III, meaning they are illegal to produce, sell, or possess except if authorized for specific purposes. This classification creates significant barriers for cluster headache patients seeking these potentially life-changing treatments, as there are currently no approved prescription products containing psilocybin or similar psychedelics available through pharmacies.

However, Canada has established several pathways for legal access to psychedelics in exceptional circumstances. The Special Access Program (SAP) allows healthcare practitioners to request access to unapproved drugs for patients with serious conditions when conventional treatments have failed. Since January 2022, Health Canada has explicitly added psilocybin and MDMA to substances that can be considered under the SAP. Additionally, individual Section 56 exemptions can be granted by the Minister of Health, allowing specific patients to legally possess and use otherwise prohibited psychedelics for medical purposes. Recently, a landmark case involving a cluster headache patient successfully gained legal access to psilocybin through these mechanisms, establishing an important precedent for others with this devastating condition.

While these pathways exist, they remain challenging to navigate and require supportive healthcare providers willing to champion patients' needs. Clinical trials represent another avenue for legal access, though availability for cluster headache-specific research in Canada is currently limited. As research continues to demonstrate the potential of psychedelics for treating conditions like cluster headaches, these access pathways may gradually expand, offering hope to patients for whom conventional treatments provide inadequate relief.

Help us accelerate access to psychedelic therapies for cluster headache in Canada by signing our open letter.